Vakharia is assistant professor of dermatology at Northwestern University Feinberg School of Medicine in Chicago. The information here represents his knowledge and experience as a medical professional ...

Prurigo nodularis is an extremely itchy skin condition. It causes a rash that often includes hard lumps called nodules. You might also hear it called nodular prurigo. Doctors don’t know exactly what ...

Paris and Tarrytown, N.Y. September 28, 2022. The U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for the treatment of adult patients with prurigo nodularis. With this ...

Please provide your email address to receive an email when new articles are posted on . Prurigo nodularis, a chronic debilitating inflammatory skin disease that causes extreme quality of life ...

Prurigo nodularis (PN) is a chronic inflammatory skin condition characterized by firm, itchy, and often painful bumps (nodules) on the skin. It typically begins with intense itchiness, which can be ...

Galderma has received filing acceptances for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with moderate-to-severe atopic dermatitis in Australia, ...

The field of prurigo nodularis has seen landmark updates in the past 5 years, with clinicians expecting more potential ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SWX:GALD) today announced that full results from the phase III OLYMPIA 1 trial, a 24-week study which evaluated the efficacy and safety of nemolizumab ...

About 75,000 adults in the U.S. living with prurigo nodularis are most in need of new treatment options. TARRYTOWN, N.Y. and PARIS, Sept. 28, 2022/ PRNewswire/-- Regeneron Pharmaceuticals, Inc. and ...